Cargando…
Exploring the Complementarity of Pancreatic Ductal Adenocarcinoma Preclinical Models
SIMPLE SUMMARY: Pancreatic ductal adenocarcinoma (PDAC) patient care lacks well-established molecular characterization of the tumors, which would allow for better-personalized treatment selection if improved. To overcome this problem, preclinical models are frequent-ly adopted tools used to elucidat...
Autores principales: | Hoare, Owen, Fraunhoffer, Nicolas, Elkaoutari, Abdessamad, Gayet, Odile, Bigonnet, Martin, Roques, Julie, Nicolle, Rémy, McGuckin, Colin, Forraz, Nico, Sohier, Emilie, Tonon, Laurie, Wajda, Pauline, Boyault, Sandrine, Attignon, Valéry, Tabone-Eglinger, Séverine, Barbier, Sandrine, Mignard, Caroline, Duchamp, Olivier, Iovanna, Juan, Dusetti, Nelson J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8161239/ https://www.ncbi.nlm.nih.gov/pubmed/34069519 http://dx.doi.org/10.3390/cancers13102473 |
Ejemplares similares
-
Multi-omics data integration and modeling unravels new mechanisms for pancreatic cancer and improves prognostic prediction
por: Fraunhoffer, Nicolas A., et al.
Publicado: (2022) -
Inhibition of glucuronidation in pancreatic cancer improves gemcitabine anticancer activity
por: Fraunhoffer, Nicolas Alejandro, et al.
Publicado: (2022) -
Metabolomic profiling of pancreatic adenocarcinoma reveals key features driving clinical outcome and drug resistance
por: Kaoutari, Abdessamad El, et al.
Publicado: (2021) -
Pancreatic ductal adenocarcinoma ubiquitination profiling reveals specific prognostic and theranostic markers
por: El Kaoutari, Abdessamad, et al.
Publicado: (2023) -
A glycosyltransferase gene signature to detect pancreatic ductal adenocarcinoma patients with poor prognosis
por: Mohamed Abd-El-Halim, Yousra, et al.
Publicado: (2021)